View Older Stories View More Recent Stories

Mar 2, 2023 09:16AM Myriad Genetics (MYGN) and Illumina (ILMN) Expand Partnership for HRD Testing in the US
Mar 2, 2023 09:15AM Illumina and Myriad Genetics expand partnership to broaden access to HRD testing in the United States
Mar 2, 2023 09:15AM Illumina and Myriad Genetics expand partnership to broaden access to HRD testing in the United States
Mar 2, 2023 09:15AM Illumina and Myriad Genetics expand partnership to broaden access to HRD testing in the United States
Feb 27, 2023 04:10PM Illumina To Webcast Upcoming Investor Conference
Feb 23, 2023 09:00AM John Hancock expands access to GalleriĀ®, GRAIL's breakthrough cancer screening technology
Feb 8, 2023 12:30PM Illumina delivers first NovaSeq X Plus sequencer to the Broad Institute
Feb 7, 2023 04:05PM Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2022
Feb 1, 2023 09:16AM Illumina (ILMN) Appoints Joydeep Goswami as CFO
Feb 1, 2023 09:15AM Illumina Appoints Joydeep Goswami Chief Financial Officer
Jan 10, 2023 04:05PM Illumina to Announce Fourth Quarter and Full Year 2022 Financial Results on Tuesday, February 7, 2023
Jan 9, 2023 09:00AM Illumina and Nashville Biosciences Announce Sequencing Agreement with Amgen
Dec 19, 2022 04:05PM Illumina To Webcast Upcoming Investor Conference
Dec 14, 2022 09:15AM Illumina Ranks Among Top Scores on Dow Jones Sustainability Index and CDP
Nov 15, 2022 04:05PM Illumina To Webcast Upcoming Investor Conferences
Nov 3, 2022 04:05PM Illumina Reports Financial Results for Third Quarter of Fiscal Year 2022
Nov 2, 2022 10:15AM ANAVASI DIAGNOSTICS ANNOUNCES NEWLY ELECTED OUTSIDE BOARD OF DIRECTORS
Nov 2, 2022 08:02AM Twist Bioscience Corporation (TWST) and Illumina (ILMN) Partner to Produce Robust Exome Panel to Advance Research
Nov 2, 2022 08:00AM Twist Bioscience and Illumina Partner to Produce Robust Exome Panel to Advance Research
Nov 1, 2022 09:00AM Illumina Introduces New Research Test to Address One of the Most Common Infections in the United States
Oct 18, 2022 06:00AM Illumina and GenoScreen Partner to Expand Access to Genomic Testing for Multidrug-Resistant Tuberculosis
Oct 17, 2022 04:05PM Illumina to Host Second Annual Virtual ESG Investor Event on Friday, October 28, 2022
Oct 11, 2022 09:16AM Illumina (ILMN) Enters Strategic Research Collaboration with AstraZeneca (AZN) to Accelerate Drug Target Discovery
Oct 11, 2022 09:15AM Illumina Launches Strategic Research Collaboration with AstraZeneca to Accelerate Drug Target Discovery
Oct 6, 2022 04:05PM Illumina to Announce Third Quarter 2022 Financial Results on Thursday, November 3, 2022
Sep 29, 2022 05:00PM Illumina (ILMN) Introduces Multiple Breakthrough Sequencing Innovations at Inaugural Genomics Forum
Sep 29, 2022 05:00PM Illumina Introduces Multiple Breakthrough Sequencing Innovations at Inaugural Genomics Forum
Sep 29, 2022 01:03PM Illumina (ILMN) Announces Launch of NovaSeq X Series
Sep 29, 2022 01:00PM Illumina Unveils Revolutionary NovaSeq X Series to Rapidly Accelerate Genomic Discoveries and Improve Human Health
Sep 26, 2022 09:15AM Illumina Genomics Forum Sold Out, Announces Opportunity to View Innovation Roadmap Session via Livestream
Sep 20, 2022 09:00AM John Hancock becomes the first life insurance carrier to offer access to GRAIL's multi-cancer early detection test to customers
Sep 19, 2022 04:05PM Illumina to Host Upcoming Investor Day
Sep 19, 2022 09:15AM Illumina Genomics Forum to Feature Nobel Laureate Frances Arnold as part of Distinguished Panel on How the Genomics Revolution Is Transforming Patient Care
Sep 14, 2022 09:15AM Illumina (ILMN) Announces New Round of Startup Investments
Sep 14, 2022 09:15AM Illumina Accelerator Invests in the Fifth Global Funding Cycle of Startups Advancing Breakthrough Therapeutics, Diagnostics, Women's Health, and Sustainable Agriculture Applications
Sep 12, 2022 09:15AM Illumina Genomics Forum to Convene Leading Visionaries to Explore Architecting Health's Radically New Infrastructure
Sep 8, 2022 06:15AM llumina Announces Opportunity to View Live Webcast of Illumina Genomics Forum Innovation Roadmap Session Followed by Investor Conference Call
Sep 7, 2022 10:34AM Illumina Genomics Forum to Feature Diverse Lineup of Visionary Global Leaders
Sep 6, 2022 07:26AM Illumina (ILMN) Intends to Appeal European Commission's Decision in GRAIL Deal
Sep 6, 2022 07:25AM Illumina Intends to Appeal European Commission's Decision in GRAIL Deal
Sep 1, 2022 01:00PM Administrative Law Judge Rules in Favor of Illumina in FTC Challenge of GRAIL Deal
Aug 30, 2022 09:15AM Illumina Deepens Commitment to Customers in China with New Manufacturing Site
Aug 29, 2022 09:15AM Illumina Genomics Forum to Feature Tennis Legend Chris Evert on the Role Genomics Played in her Cancer Fight
Aug 22, 2022 09:15AM Illumina Genomics Forum to Feature 23andMe Co-founder and CEO Anne Wojcicki
Aug 16, 2022 05:00PM Minderoo Foundation and Illumina Commit $40M AUD to Apply Advanced Genomics to Marine Conservation
Aug 15, 2022 09:15AM Illumina Genomics Forum to Feature American Cancer Society CEO Karen Knudsen on the Future of Cancer Genomics
Aug 11, 2022 04:05PM Illumina Reports Financial Results for Second Quarter of Fiscal Year 2022
Aug 8, 2022 09:15AM Illumina Genomics Forum to Feature Bill Gates and Distinguished Health Leaders Addressing Need for Global Access to Genomics
Jul 27, 2022 09:15AM Illumina Unveils its Most Accurate and Comprehensive Secondary Analysis Platform, Boosting Lab Capabilities
Jul 18, 2022 09:15AM Illumina Announces Inaugural Illumina Genomics Forum with a Conversation with Former U.S. President Barack Obama
View More Recent Stories View Older Stories